131 related articles for article (PubMed ID: 11372662)
21. Protein C and S and inflammation in sickle cell disease.
Schnog JB; Mac Gillavry MR; van Zanten AP; Meijers JC; Rojer RA; Duits AJ; ten Cate H; Brandjes DP
Am J Hematol; 2004 May; 76(1):26-32. PubMed ID: 15114593
[TBL] [Abstract][Full Text] [Related]
22. Protein C pathway in infants and children.
Petäjä J; Manco-Johnson MJ
Semin Thromb Hemost; 2003 Aug; 29(4):349-62. PubMed ID: 14517747
[TBL] [Abstract][Full Text] [Related]
23. Protein C, protein S, and antithrombin III in twice-frozen plasma.
Sivakumaran M; Long S; Drury M
Transfusion; 2005 Feb; 45(2):281. PubMed ID: 15660840
[No Abstract] [Full Text] [Related]
24. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
Dahlbäck B; Villoutreix BO
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1311-20. PubMed ID: 15860736
[TBL] [Abstract][Full Text] [Related]
25. The tale of protein S and C4b-binding protein, a story of affection.
Dahlbäck B
Thromb Haemost; 2007 Jul; 98(1):90-6. PubMed ID: 17597997
[No Abstract] [Full Text] [Related]
26. Inflammation and the activated protein C anticoagulant pathway.
Esmon CT
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():49-60. PubMed ID: 16673266
[TBL] [Abstract][Full Text] [Related]
27. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.
Zürcher M; Sulzer I; Barizzi G; Lämmle B; Alberio L
Thromb Haemost; 2008 Feb; 99(2):416-26. PubMed ID: 18278194
[TBL] [Abstract][Full Text] [Related]
28. The impact of the inflammatory response on coagulation.
Esmon CT
Thromb Res; 2004; 114(5-6):321-7. PubMed ID: 15507261
[TBL] [Abstract][Full Text] [Related]
29. Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.
Adrie C; Monchi M; Laurent I; Um S; Yan SB; Thuong M; Cariou A; Charpentier J; Dhainaut JF
J Am Coll Cardiol; 2005 Jul; 46(1):21-8. PubMed ID: 15992630
[TBL] [Abstract][Full Text] [Related]
30. [The numerous properties of the anticoagulant protein C].
Cerchiara E; Tirindelli MC; Giannetti B; Dicuonzo G; Avvisati G
Clin Ter; 2007; 158(2):181-7. PubMed ID: 17566522
[TBL] [Abstract][Full Text] [Related]
31. Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade.
Vieira CS; Ferriani RA; Garcia AA; Pintão MC; Azevedo GD; Gomes MK; Silva-de-Sá MF
Hum Reprod; 2007 Aug; 22(8):2196-201. PubMed ID: 17569674
[TBL] [Abstract][Full Text] [Related]
32. Hypercoagulable state in five thalassemia intermedia patients.
Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
[TBL] [Abstract][Full Text] [Related]
33. Coagulation and inflammation.
Esmon CT
J Endotoxin Res; 2003; 9(3):192-8. PubMed ID: 12831462
[TBL] [Abstract][Full Text] [Related]
34. Targeting exosites of activated protein C as therapeutic possibility?
Dahlbäck B
Thromb Res; 2014 Jun; 133(6):963-4. PubMed ID: 24612601
[No Abstract] [Full Text] [Related]
35. Regulation of coagulation by protein S.
Castoldi E; Hackeng TM
Curr Opin Hematol; 2008 Sep; 15(5):529-36. PubMed ID: 18695379
[TBL] [Abstract][Full Text] [Related]
36. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
[TBL] [Abstract][Full Text] [Related]
37. Mitigation of coagulation by removing clotting factors part 1: in vitro feasibility study.
Parker JT; Beutler DS; Sukavaneshvar S; Jacobs N; Solen KA; Mohammad SF
ASAIO J; 2007; 53(4):415-20. PubMed ID: 17667224
[TBL] [Abstract][Full Text] [Related]
38. The coagulation system and pulmonary endothelial function in acute lung injury.
Finigan JH
Microvasc Res; 2009 Jan; 77(1):35-8. PubMed ID: 18938186
[TBL] [Abstract][Full Text] [Related]
39. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
[TBL] [Abstract][Full Text] [Related]
40. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
